MR-IMPACT: Comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial

European Heart Journal

Volumn 29, Issue 4, 2008, Pages 480-489

  Schwitter, Juerg ^a   Wacker, Christian M ^b   Van Rossum, Albert C ^c   Lombardi, Massimo ^d   Al Saadi, Nidal ^e   Ahlstrom, Hakan ^f   Dill, Thorsten ^g   Larsson, Henrik B W ^h   Flamm, Scott D ⁱ   Marquardt, Moritz ^j   Johansson, Lars ^f  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^g KERCKHOFF HEART CENTER   (Germany)

^h TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

ⁱ ST LUKE S EPISCOPAL HOSPITAL   (United States)

^j GE HEALTHCARE   (Germany)

more..

Author keywords

Contrast medium; Coronary artery disease; Magnetic resonance imaging; Myocardial perfusion; Quantitative X ray coronary angiography; Single photon emission computed tomography

Indexed keywords

ADENOSINE; ANTITHROMBIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PENTETIC ACID; TECHNETIUM 99M; THALLIUM 201;

ADULT; AGED; ANGIOCARDIOGRAPHY; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY X RAY ANGIOGRAPHY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE; PERFUSION CARDIAC MAGNETIC RESONANCE; PERFUSION WEIGHTED IMAGING; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ROC CURVE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; CORONARY ARTERY DISEASE; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 39349085553     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehm617     Document Type: Article

References (33)

1. Silber S, Albertsson P, Aviles F, Camici P, Colombo A, Hamm C, Jorgensen E, Marco J, Nordrehaug J-E, Ruzyllo W, Urban P, Stone G, Wijns W. Guidelines for percutaneous coronary interventions. Eur Heart J 2005;26:804-847.
2. Shaw LJ, Hachamovitch R, Berman D, Marwick T, Lauer M, Heller G, Iskandrian A, Kesler K, Travin M, Lewin H, Hendel R, Borges-Neto S, Miller D. The economic consequence of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischemia. J Am Coll Cardiol 1999;33:661-669.
3. Beller GA, Zaret BL. Contributions of nuclear cardiology to diagnosis and prognosis of patients wiht coronary artery disease. Circulation 2000;101:1465-1478.
4. Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA, Friedman J, Diamond GA. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction [erratum appears in Circulation 1998 Jul 14;98(2):190]. Circulation 1998;97:535-543.
5. Schwitter J, Nanz D, Kneifel S, Bertschinger K, Buchi M, Knusel PR, Marincek B, Luscher TF, von Schulthess GK. Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography. Circulation 2001;103:2230-2235.
6. Al-Saadi N, Nagel E, Gross M, Bornstedt A, Schnackenburg B, Klein C, Klimek W, Oswald H, Fleck E. Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation 2000;101:1379-1383.
7. Klem I, Heitner JF, Shah DJ, Sketch MH Jr, Behar V, Weinsaft J, Cawley P, Parker M, Elliott M, Judd RM, Kim RJ. Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging. J Am Coll Cardiol 2006;47:1630-1638.
8. Paetsch I, Jahnke C, Wahl A, Gebker R, Neuss M, Fleck E, Nagel E. Comparison of dobutamine stress magnetic resonance, adenosine stress magnetic resonance, and adenosine stress magnetic resonance perfusion. Circulation 2004;110:835-842.
9. Panting JR, Gatehouse PD, Yang GZ, Jerosch-Herold M, Wilke N, Firmin DN, Pennell DJ. Echo-planar magnetic resonance myocardial perfusion imaging: parametric map analysis and comparison with thallium SPECT. J Cardiovasc Magn Reson 2001;13:192-200.
10. Wolff S, Schwitter J, Coulden R, Friedrich M, Bluemke D, Biedermann R, Martin E, Lansky A, Kashanian F, Foo T, Licato P, Comeau C. Myocardial first-pass perfusion magnetic resonance imaging: a multicenter dose-ranging study. Circulation 2004;110:732-737.
11. Giang T, Nanz D, Coulden R, Friedrich M, Graves M, Al-Saadi N, Lüscher T, von Schulthess G, Schwitter J. Detection of coronary artery disease by magnetic resonance myocardial perfusion imaging with various contrast medium doses: first European multicenter experience. Eur Heart J 2004;25:1657-1665.
12. Panting JR, Gatehouse PD, Yang GZ, Grothues F, Firmin DN, Collins P, Pennell DJ. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med 2002;346:1948-1953.
13. Ishida N, Sakuma H, Motoyasu M, Okinaka T, Isaka N, Nakano T, Takeda K. Noninfarcted myocardium: correlation between dynamic first-pass contrast-enhanced myocardial MR imaging and quantitative coronary angiography. Radiology 2003;229:209-216.
14. Ingkanisorn W, Kwong R, Bohme N, Geller N, Rhoads K, Dyke C, Paterson D, Syed M, Aletras A, Arai A. Prognosis of negative adenosine stress magnetic resonance in patients presenting to an emergency department with chest pain. J Am Coll Cardiol 2006;47:1427-1432.
15. Hendel RC, Berman DS, Cullom SJ, Follansbee W, Heller GV, Kiat H, Groch MW, Mahmarian JJ. Multicenter clinical trial to evaluate the efficacy of correction for photon attenuation and scatter in SPECTmyocardial perfusion imaging. Circulation 1999;99:2742-2749.
16. Swets JA. Measuring the accuracy of diagnostic systems. Science 1988;240:1285-1293.
17. Zou K, O'Malley A, Mauri L. Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models. Circulation 2007;115:654-657.
18. Hanley J, McNeil B. The meaning and use of the area under the receiver operating characteristics (ROC) curve. Radiology 1982:29-36.
19. American Society of Nuclear Cardiology. Imaging guidelines for nuclear cardiology procedures, part 1. J Nucl Cardiol 1996;3:G1-G46.
20. Seiler C, Kirkeeide RL, Gould KL. Basic structure-function relations of the epicardial coronary vascular tree. Basis of quantitative coronary arteriography for diffuse coronary artery disease. Circulation 1992;85:1987-2003.
21. Elkington AG, Gatehouse PD, Prasad SK, Moon JC, Firmin DN, Pennell DJ. Combined long- and short-axis myocardial perfusion cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2004;6:811-816.
22. Wang Y, Moin K, Mathew S, Akinboboye O, Reichek N. Myocardial first-pass perfusion assessment using rotational long-axis MRI. J Magn Reson Imaging 2005;22:53-58.
23. Cerqueira M, Verani M, Schwaiger M, Heo J, Iskandrian A. Safety profile of adenosine stress perfusion imaging: results from the Adenoscan Multicenter Trial Registry. J Am Coll Cardiol 1994;23:384-389.
24. American Heart Association. Heart disease and stroke statistics: Update 2005. American Heart Association, 2005
25. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-1453.
26. Wagner A, Mahrholdt H, Holly T, Kim RJ. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial infarcts: an imaging study. Lancet 2003;361:374-379.
27. Kramer CM. When two tests are better than one: adding late gadolinium enhancement to first-pass perfusion cardiovascular magnetic resonance. J Am Coll Cardiol 2006;47:1639-1640.
28. Knuesel PR, Nanz D, Wyss C, Buechi M, Kaufmann PA, von Schulthess GK, Luscher TF, Schwitter J. Characterization of dysfunctional myocardium by positron emission tomography and magnetic resonance: relation to functional outcome after revascularization. Circulation 2003;108:1095-1100.
29. Van Train KF, Garcia EV, Maddahi J, Areeda J, Cooke CD, Kiat H, Silagan G, Folks R, Friedman J, Matzer L et al. Multicenter trial validation for quantitative analysis of same-day rest-stress technetium-99m-sestamibi myocardial tomograms. J Nucl Med 1994;35:609-618.
30. He ZX, Iskandrian AS, Gupta NC, Verani MS. Assessing coronary artery disease with dipyridamole technetium-99m-tetrofosmin SPECT: a multicenter trial. J Nuc Med 1997;38:44-48.
31. Zaret BL, Rigo P, Wackers FJ, Hendel RC, Braat SH, Iskandrian AS, Sridhara BS, Jain D, Itti R, Serafini AN et al. Myocardial perfusion imaging with 99mTc tetrofosmin. Comparison to 201Tl imaging and coronary angiography in a phase III multicenter trial. Tetrofosmin International Trial Study Group. Circulation 1995;91:313-319.
32. Smanio P, Watson D, Segalla D, Vinson E, Smith W, Beller G. Value of gating of Technetium-99m sestamibi single-photon emission computed tomographic imaging. J Am Coll Cardiol 1997;30:1687-1692.
33. Lima RS, Watson DD, Goode AR, Siadaty MS, Ragosta M, Beller GA, Samady H. Incremental value of combined perfusion and function over perfusion alone by gated SPECT myocardial perfusion imaging for detection of severe three-vessel coronary artery disease. J Am Coll Cardiol 2003;42:64-70.